This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
The GLP-1 pricing database: every offering, every provider, one honest number
86 priceable self-pay offerings across 18 providers, plus NexLife's 24 price points. Sorted on total monthly cost — medication plus any required membership.
Direct answer
What we evaluated: every publicly advertised self-pay offering we could source: 86 offerings across 18 providers, plus NexLife's six programmes at four plan lengths
Date verified: July 6, 2026 (competitors) and July 11, 2026 (NexLife)
Direct answer: the cheapest FDA-approved option is $149/month — Foundayo (oral) via LillyDirect, or the oral Wegovy tablet via NovoCare. The cheapest compounded options are NexLife's semaglutide microdose at $110 and Oak Longevity's semaglutide at $133
Necessary qualification: an FDA-approved oral pill at $149 now undercuts most of the compounded market, so 'compounded is cheaper' is no longer reliably true. Microdose programmes sit below every dose studied in the trials. Committed-plan rates are not month-to-month rates, and introductory rates are not ongoing rates — we keep all of these separate
Method: every figure is a total ongoing monthly cost (medication + any required membership), derived by plan total ÷ plan months. See our pricing-verification methodology.
The three rules we sort by
1. Total, not medication. Every figure below is medication plus any membership you cannot decline. Eden quotes $99 for compounded semaglutide; the membership is required, so the number here is $198.
2. Ongoing, not introductory. Eleven of these offerings are first-month rates. They are flagged and excluded from every ranking.
3. Monthly equivalent = plan total ÷ plan months. Where a price depends on a commitment, we publish the plan total beside the monthly figure so the arithmetic is checkable.
Why we label prices instead of just listing themEvery price in this database was captured from the provider's own published pages and confirmed on July 6, 2026. That is what our Verified label means: a dated capture against the source, not a figure copied from another comparison site.
The distinction matters, because comparison sites in this category publish flatly contradictory numbers for the same providers. Our own capture corrected two of them: a stored TrimRx figure of $259 that matched no current checkout tier, and an Eden brand-Zepbound figure of $299 that turned out to be LillyDirect's price, not Eden's — Eden's real price is $1,399.
Prices change. This capture is dated, and a figure more than about thirty days old should be confirmed at checkout. What we will not do is mark something Verified because someone else published it.
The distinction matters, because comparison sites in this category publish flatly contradictory numbers for the same providers. Our own capture corrected two of them: a stored TrimRx figure of $259 that matched no current checkout tier, and an Eden brand-Zepbound figure of $299 that turned out to be LillyDirect's price, not Eden's — Eden's real price is $1,399.
Prices change. This capture is dated, and a figure more than about thirty days old should be confirmed at checkout. What we will not do is mark something Verified because someone else published it.
Compounded tirzepatide — 17 offerings
Total = medication + any required membership. Introductory rates excluded. Brand Zepbound starts at $299 and brand Foundayo (oral, FDA-approved) at $149 — several compounded programmes here cost more than both.
| Provider | TOTAL / month | Format | Billing | Notes |
|---|---|---|---|---|
| NexLife | $147/mo | Injectable | All-inclusive | Microdose. 12-month plan ($1,764 total). Month-to-month $189; 6-month $150; 3-month $160. No membership fee, flat at every covered dose. Below every dose studied in the trials. Verified |
| Found | $169/mo | Injectable | All-inclusive | 12-month PREPAID. Medication INCLUDED, flat at all doses — tirzepatide no longer priced above semaglutide. 6-month ~$199; month-to-month $289. Verified |
| Enhance.MD | $169/mo | Injectable | All-inclusive | Microdose, 1mg/week. Delivery every 12 weeks. All-inclusive (medication, care, lab testing, shipping). Verified |
| NexLife | $186/mo | Injectable | All-inclusive | Standard injection. 12-month plan ($2,232 total). Month-to-month $215; 6-month $190; 3-month $195. No membership fee, flat at every covered dose. Verified |
| Shed | $199/mo | Injectable | All-inclusive | Microdose programme. 2-month minimum. Verified |
| Oak Longevity | $199/mo | Injectable | All-inclusive | Flat across all dosages, no subscription. ~$233-$299 month-to-month. Verified |
| NexLife | $199/mo | Oral / pill | All-inclusive | Oral tablet (ODT). 12-month plan ($2,388 total). Month-to-month $229; 6-month $205; 3-month $219. No membership fee, flat at every covered dose. NO TRIAL EVIDENCE for this dosage form. Verified |
| Shed | $229/mo | Sublingual | All-inclusive | 'GLP-1 Liquid Drops' (was $419). 2-month minimum. Verified |
| Shed | $245/mo | Injectable | All-inclusive | 12-month plan paid upfront. 6-month $279; month-to-month $349. INCREASES at higher doses. Verified |
| Mochi Health | $278/mo | Injectable | $199 med + $79 membership | $199 med + $79 membership ($39 first month). Same price at all doses. Verified |
| Enhance.MD | $280/mo | Injectable | All-inclusive | 12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329. Verified |
| Eden | $298/mo | Injectable | $199 med + $99 membership | $199 med (flat at every dose) + $99 membership (REQUIRED). Verified |
| Noom Med | $299/mo | Injectable | All-inclusive | Full dose. First month $149. Billed quarterly. Verified |
| Henry Meds | $349/mo | Oral / pill | All-inclusive | ORAL TABLETS ONLY — Henry Meds does NOT offer injectable tirzepatide. 3-month subscription; $297 paid in full. Verified |
| TrimRx | $349/mo | Injectable | All-inclusive | Flat rate, all doses, no membership. Month-to-month: $279 first month then $399 ongoing. Prepay: $316 (3-mo), $299 (6-mo), $283 (12-mo). Verified |
| MEDVi | $399/mo | Injectable | All-inclusive | Refill rate at lower doses; 10/12.5/15mg reach $499. First month ~$279. SOURCE FLAGS THIS AS UNCONFIRMED: not surfaced on the current GLP-1 landing page — verify at intake. Evaluation in progress |
| bmiMD | $399/mo | Injectable | All-inclusive | All-inclusive. Tirzepatide micro-dose: $349. Verified |
Compounded semaglutide — 20 offerings
Total = medication + any required membership. The oral Wegovy tablet (brand, FDA-approved) is $149.
| Provider | TOTAL / month | Format | Billing | Notes |
|---|---|---|---|---|
| NexLife | $110/mo | Injectable | All-inclusive | Microdose. 12-month plan ($1,320 total). Month-to-month $129; 6-month $114; 3-month $119. No membership fee, flat at every covered dose. Below every dose studied in the trials. Verified |
| Oak Longevity | $133/mo | Injectable | All-inclusive | Flat across all dosages, no subscription. ~$167-$199 month-to-month. NOT available in California. Verified |
| NexLife | $145/mo | Injectable | All-inclusive | Standard injection. 12-month plan ($1,740 total). Month-to-month $165; 6-month $147; 3-month $149. No membership fee, flat at every covered dose. Verified |
| Shed | $149/mo | Injectable | All-inclusive | Microdose programme — lower dose, for tolerability or maintenance. 2-month minimum. Verified |
| NexLife | $165/mo | Oral / pill | All-inclusive | Oral tablet (ODT). 12-month plan ($1,980 total). Month-to-month $199; 6-month $177; 3-month $185. No membership fee, flat at every covered dose. NO TRIAL EVIDENCE for this dosage form. Verified |
| Found | $169/mo | Injectable | All-inclusive | 12-month PREPAID. Medication INCLUDED, flat across all compounded GLP-1s and all doses. 6-month ~$199; month-to-month $289. Verified |
| Shed | $175/mo | Injectable | All-inclusive | 12-month plan paid upfront. 6-month $199; month-to-month $249. INCREASES at higher doses. Verified |
| Mochi Health | $178/mo | Injectable | $99 med + $79 membership | $99 med + $79 membership ($39 first month). Same price at all doses. Unlimited physician + dietitian access. Verified |
| Henry Meds | $179/mo | Sublingual | All-inclusive | Sublingual tablets or drops, absorbed under the tongue. All-inclusive. Verified |
| Eden | $198/mo | Injectable | $99 med + $99 membership | $99 med (flat at every dose) + $99 membership. Membership REQUIRED for any medication. Verified |
| Noom Med | $199/mo | Injectable | All-inclusive | CAPPED AT 0.6mg MAX DOSE — below the 2.4mg used in the STEP trials. Billed quarterly. Verified |
| TrimRx | $199/mo | Injectable | All-inclusive | Flat rate, all doses, no membership. Month-to-month: $179 first month then $299 ongoing. Prepay: $209 (3-mo), $191 (6-mo), $174 (12-mo). Verified |
| Shed | $199/mo | Sublingual | All-inclusive | Daily dissolvable lozenges, month-to-month, medication and supplies included (was $299). Verified |
| Enhance.MD | $212/mo | Injectable | All-inclusive | 12-month plan. Same price at all doses. 6-month $224; 3-month $237; month-to-month $249. Verified |
| Shed | $229/mo | Sublingual | All-inclusive | 'GLP-1 Liquid Drops' — medication and supplies included (was $329). 2-month minimum. Verified |
| Henry Meds | $249/mo | Oral / pill | All-inclusive | 3-month subscription ($747/12wks); $179/mo paid in full ($537/12wks). 3-month minimum. Verified |
| bmiMD | $289/mo | Injectable | All-inclusive | All-inclusive. CA/NC residents: $379.99. Micro-dose: same $289. Verified |
| Henry Meds | $297/mo | Injectable | All-inclusive | Month-to-month. 6-month paid in full: $247 ($1,482 upfront). 12-month paid in full: $197 ($2,364 upfront). Verified |
| MEDVi | $299/mo | Injectable | All-inclusive | Refill rate, locked in. First month $179. Verified |
| MEDVi | $369/mo | Oral / pill | All-inclusive | Oral semaglutide tablet refill rate. SOURCE FLAGS THIS AS third-party reporting rather than a direct capture. First month $249. Evaluation in progress |
A capped dose is not a discountWatch for dose caps as well as dose escalation. Noom Med's $199 compounded semaglutide programme is capped at 0.6mg — the STEP trials that established semaglutide's efficacy used 2.4mg. A capped programme is not a cheaper version of the same treatment; it is a lower-dose treatment, and the expected effect is correspondingly smaller. Noom's full-titration programme is $279.
Compounded liraglutide — 2 offerings
Liraglutide is a daily injection rather than weekly, which is the main practical difference. It is also meaningfully less effective: SCALE found roughly 8% mean weight reduction, against 14.9% for semaglutide in STEP 1 and 20.9% for tirzepatide in SURMOUNT-1. It is rarely the right choice on effectiveness, and it is not cheaper.
| Provider | TOTAL / month | Format | Billing | Notes |
|---|---|---|---|---|
| Found | $169/mo | Injectable | All-inclusive | DAILY injection. 12-month PREPAID, medication included, flat across all compounded GLP-1s. Verified |
| Henry Meds | $179/mo | Injectable | All-inclusive | Month-to-month. 6-month paid in full: $149 ($894 upfront). 12-month paid in full: $119 ($1,428 upfront). Verified |
Brand-name GLP-1 — 42 offerings
This is the section most comparison sites get wrong, because brand prices fell sharply in late 2025 and the tables never got updated. Read the manufacturer-direct rows first.
| Provider | TOTAL / month | Format | Billing | Notes |
|---|---|---|---|---|
| LillyDirect | $149/mo | Oral / pill | Manufacturer direct | 0.8mg starter, Self Pay Journey Program. CHEAPEST verified path to an FDA-approved oral GLP-1 for weight loss. Verified |
| NovoCare Pharmacy | $149/mo | Oral / pill | Manufacturer direct | Wegovy TABLETS, 1.5mg and 4mg. Cheapest verified path to FDA-approved ORAL semaglutide for weight loss. Verified |
| LillyDirect | $199/mo | Oral / pill | Manufacturer direct | 2.5mg — step-up dose between starter and maintenance. Verified |
| Found | $248/mo | Oral / pill | $149 med + $99 membership | $149 med (0.8mg starter) + $99 CORE membership on 12-month plan. Escalates by dose. Verified |
| Shed | $274/mo | Oral / pill | $149 med + $125 membership | $149 med (starter) + $125 membership. Fulfilled via LillyDirect. Escalates $149->$199->$299 by dose tier. Verified |
| Shed | $274/mo | Oral / pill | $149 med + $125 membership | Wegovy pill $149-$299 by dose + $125 membership (required for brand). Verified |
| Found | $297/mo | Oral / pill | $198 med + $99 membership | $198 Wegovy pill + $99 CORE membership on 12-month plan. Verified |
| Hims | $298/mo | Oral / pill | $149 med + $149 membership | $149 med (0.8mg starter) + $149 membership ($39 first month). Higher doses cost more. Verified |
| Hers | $298/mo | Oral / pill | $149 med + $149 membership | $149 med (starter) + $149 membership ($39 first month). Higher doses cost more. Verified |
| Hims | $298/mo | Oral / pill | $149 med + $149 membership | $149 Wegovy pill + $149 membership ($39 first month). Same price at all doses. Verified |
| Hers | $298/mo | Oral / pill | $149 med + $149 membership | $149 Wegovy pill + $149 membership ($39 first month). Verified |
| LillyDirect | $299/mo | Oral / pill | Manufacturer direct | 5.5mg and 9mg — mid maintenance dose. Verified |
| LillyDirect | $299/mo | Injectable | Manufacturer direct | 2.5mg starter, Self Pay Journey Program. 5mg $399; 7.5-15mg $449. Verified |
| PlushCare | $319/mo | Injectable | $299 med + $20 membership | $299 Zepbound 2.5mg vial + $19.99 membership. 5mg $399; 7.5mg+ $449. Cheapest membership in the category. Verified |
| WeightWatchers Clinic | $323/mo | Injectable | $249 med + $74 membership | $249 med (12-month supply PAID UPFRONT, $2,988) + $74/mo WW Med+ membership. Verified |
| Shed | $324/mo | Injectable | $199 med + $125 membership | Wegovy PEN from $199 (higher doses more) + $125 membership. Prior $149 reflected the pill, not the pen. Verified |
| Found | $347/mo | Injectable | $248 med + $99 membership | $248 Wegovy pen + $99 CORE membership on 12-month plan. Verified |
| Ro | $348/mo | Oral / pill | $199 med + $149 membership | $199 med + $149 Ro Body membership. Ongoing $199-$299 by dose. First month medication $149. Verified |
| Hims | $348/mo | Injectable | $199 med + $149 membership | $199 Wegovy pen + $149 membership ($39 first month). Same price at all doses. Verified |
| Hers | $348/mo | Injectable | $199 med + $149 membership | $199 Wegovy pen + $149 membership ($39 first month). Verified |
| Ro | $348/mo | Oral / pill | $199 med + $149 membership | $199 med + $149 Ro Body membership. Annual prepay saves $50/mo; $74 membership on the annual plan. Verified |
| Ro | $348/mo | Injectable | $199 med + $149 membership | $199-$399 med by dose + $149 Ro Body membership. Annual prepay saves $150/mo on medication. Verified |
| Hims | $348/mo | Injectable | $199 med + $149 membership | $199 med + $149 membership. FDA-approved for T2D; off-label for weight loss only when clinically appropriate. Verified |
| Hers | $348/mo | Injectable | $199 med + $149 membership | $199 med starter + $149 membership ($39 first month). FDA-approved for T2D. Verified |
| LillyDirect | $349/mo | Oral / pill | Manufacturer direct | 14.5mg and 17.2mg standard rate. DROPS to $299 with a refill within 45 days of previous delivery — its own 45-day rule, parallel to Zepbound's. Verified |
| NovoCare Pharmacy | $349/mo | Injectable | Manufacturer direct | Month 3 onward, all maintenance doses. Cut from $499 in November 2025. Verified |
| NovoCare Pharmacy | $349/mo | Injectable | Manufacturer direct | 0.25-1mg ongoing; $499 for the 2mg dose. FDA-approved for T2D. Verified |
| PlushCare | $419/mo | Injectable | $399 med + $20 membership | $399 med + $19.99 membership (first month free). $129 initial visit billed separately. Verified |
| WeightWatchers Clinic | $423/mo | Injectable | $349 med + $74 membership | $349 med + $74 WW Med+ membership ($25 first month). 12-month commitment available at $249/mo. Verified |
| Found | $447/mo | Injectable | $348 med + $99 membership | $348 Zepbound KwikPen + $99 CORE membership on 12-month plan. Verified |
| Hims | $448/mo | Injectable | $299 med + $149 membership | $299 Zepbound KwikPen + $149 membership ($39 first month). Higher doses cost more. Verified |
| Hers | $448/mo | Injectable | $299 med + $149 membership | $299 Zepbound 2.5mg single-dose VIAL + $149 membership. Passes through Lilly's vial pricing: $299/$399/$449; refill within 45 days to hold the rate. NOTE: the pre-filled KwikPen is NOT in Lilly's vial-only self-pay programme, so a KwikPen price from Hers is UNCONFIRMED — verify at checkout. Verified |
| LillyDirect | $449/mo | Injectable | Manufacturer direct | 7.5mg-15mg. MUST refill within 45 days of the previous delivery or the price rises. Verified |
| Shed | $474/mo | Injectable | $349 med + $125 membership | $349 med ($349-$499 by dose) + $125 membership (required for brand). Was $299. Verified |
| Ro | $548/mo | Injectable | $399 med + $149 membership | $399-$449 med by dose + $149 Ro Body membership. First month medication $299. Verified |
| PlushCare | $1,020/mo | Injectable | $1,000 med + $20 membership | RETAIL-LEVEL (~$1,000 med + $20 membership). NovoCare's direct programme is $349-$499 for the same drug. Verified |
| PlushCare | $1,120/mo | Injectable | $1,100 med + $20 membership | RETAIL (~$1,100 med + $20 membership). Lilly runs NO Mounjaro self-pay programme. Zepbound is the same molecule at $299-$449. Verified |
| Found | $1,199/mo | Injectable | $1,100 med + $99 membership | RETAIL-LEVEL ($1,100 med + $99 membership). NovoCare sells it direct for $349. Verified |
| Found | $1,199/mo | Injectable | $1,100 med + $99 membership | RETAIL ($1,100 med + $99 membership). Zepbound is the identical molecule at $299-$449 via LillyDirect. Verified |
| Eden | $1,498/mo | Injectable | $1,399 med + $99 membership | RETAIL-LEVEL. $1,399 med + $99 membership. LillyDirect sells the identical drug for $299-$449. Verified |
| Eden | $1,794/mo | Injectable | $1,695 med + $99 membership | RETAIL-LEVEL. $1,695 med + $99 membership. NovoCare sells the identical drug direct for $149-$349. Verified |
| Hers | $2,048/mo | Injectable | $1,899 med + $149 membership | RETAIL ($1,899 med + $149 membership). No manufacturer self-pay programme exists for Mounjaro. Verified |
The cheapest FDA-approved option is now oralThe cheapest FDA-approved GLP-1 for weight loss is now oral, and it undercuts most of the compounded market. Foundayo (orforglipron) starts at $149/month at the 0.8mg dose through LillyDirect. The oral Wegovy tablet is $149/month through NovoCare at 1.5mg and 4mg.
An FDA-approved, quality-verified, manufacturer-supplied medication at $149, against a compounded market that mostly runs $169-$399. The catch is dose escalation — Foundayo rises to $199, then $299, then $349 as you titrate, and at the top doses it has its own 45-day refill rule (it drops back to $299 if you refill in time). But for a starting patient, or anyone maintaining on a lower dose, the brand oral pill is now among the cheapest legitimate options in the entire category — and almost no comparison site has caught up.
An FDA-approved, quality-verified, manufacturer-supplied medication at $149, against a compounded market that mostly runs $169-$399. The catch is dose escalation — Foundayo rises to $199, then $299, then $349 as you titrate, and at the top doses it has its own 45-day refill rule (it drops back to $299 if you refill in time). But for a starting patient, or anyone maintaining on a lower dose, the brand oral pill is now among the cheapest legitimate options in the entire category — and almost no comparison site has caught up.
The retail trap
Check the manufacturer before you buy brand through a platformSeven offerings in this database are brand-name drugs resold at close to retail, while the manufacturer sells the identical medicine direct for a fraction of the price. Eden lists brand Wegovy at $1,794/month total; NovoCare sells it for $149-$349. Eden lists brand Zepbound at $1,498; LillyDirect sells it for $299-$449. Hers lists Mounjaro at $2,048.
These are not scams — the prices are disclosed. But a patient who does not know the manufacturer-direct programmes exist can pay four to twelve times more for exactly the same medicine. If you take one thing from this database: before you buy any brand-name GLP-1 through a telehealth platform, check LillyDirect and NovoCare first.
These are not scams — the prices are disclosed. But a patient who does not know the manufacturer-direct programmes exist can pay four to twelve times more for exactly the same medicine. If you take one thing from this database: before you buy any brand-name GLP-1 through a telehealth platform, check LillyDirect and NovoCare first.
Everything below the first four bars is the SAME medicine, sold at a multiple of the manufacturer's own direct price. Check LillyDirect and NovoCare before buying any brand drug through a platform.
Never pay cash for MounjaroMounjaro and Zepbound are the same molecule — tirzepatide. The only difference is the approved indication: Mounjaro for type 2 diabetes, Zepbound for weight management.
Lilly runs a self-pay programme for Zepbound and none for Mounjaro. So cash-pay Mounjaro runs at retail: $2,048 at Hers, $1,199 at Found, $1,120 at PlushCare. Brand Zepbound through LillyDirect is $299-$449 for the identical drug.
If you are paying cash and you want tirzepatide, you want Zepbound. Mounjaro makes financial sense only when insurance covers it, which generally requires a type 2 diabetes diagnosis.
Lilly runs a self-pay programme for Zepbound and none for Mounjaro. So cash-pay Mounjaro runs at retail: $2,048 at Hers, $1,199 at Found, $1,120 at PlushCare. Brand Zepbound through LillyDirect is $299-$449 for the identical drug.
If you are paying cash and you want tirzepatide, you want Zepbound. Mounjaro makes financial sense only when insurance covers it, which generally requires a type 2 diabetes diagnosis.
Introductory rates, isolated
These eleven offerings are the ones you see in advertisements. They are real, and they last one month.
| Provider | TOTAL / month | Format | Billing | Notes |
|---|---|---|---|---|
| Noom Med INTRO RATE | $79/mo | Injectable | All-inclusive | First 4-week supply for new patients (was $99). Ongoing $199. 0.6mg max dose cap. Verified |
| Noom Med INTRO RATE | $129/mo | Injectable | All-inclusive | First month, Standard GLP-1Rx Program. Ongoing $279. Verified |
| Eden INTRO RATE | $138/mo | Injectable | $99 med + $39 membership | First month: $99 medication + $39 intro membership. Membership auto-renews at $99/mo. Verified |
| Noom Med INTRO RATE | $149/mo | Injectable | All-inclusive | First month, GLP-1Rx Plus. Discounted from $199. Ongoing $299. Verified |
| MEDVi INTRO RATE | $179/mo | Injectable | All-inclusive | First month only ('Starting at $179'). Refills are $299. Verified |
| NovoCare Pharmacy INTRO RATE | $199/mo | Injectable | Manufacturer direct | Introductory: first 2 months at 0.25/0.5mg. Escalates to $349 from month 3. Verified |
| NovoCare Pharmacy INTRO RATE | $199/mo | Injectable | Manufacturer direct | Introductory: first 2 months at 0.25-1mg. Escalates to $349 ongoing. Verified |
| Eden INTRO RATE | $238/mo | Injectable | $199 med + $39 membership | First month: $199 medication + $39 intro membership. Renews at $99/mo membership. Verified |
| Oak Longevity INTRO RATE | $245/mo | Oral / pill | All-inclusive | $245 per 4-week supply (~$266 normalised to 30 days). Dose escalation may apply. Verified |
| MEDVi INTRO RATE | $249/mo | Oral / pill | All-inclusive | Oral tablet first month. Ongoing $369. Verified |
| WeightWatchers Clinic INTRO RATE | $373/mo | Injectable | $299 med + $74 membership | $299 med + $74 membership ($25 first month). Doses outside the 45-day window can reach $849. Verified |
The intro-rate trapEleven of the eighty-nine offerings in this database are introductory rates — and they are the ones that get quoted. Noom advertises $79; the ongoing price is $199. MEDVi advertises $179; refills are $299. TrimRx's $179 becomes $299. Eden's $39 membership becomes $99. Oak's oral $245 is a four-week supply, which is $266 normalised to a month.
You pay the ongoing rate for eleven of your twelve months. That is why every table on this site sorts on the ongoing total — medication plus any required membership — and flags introductory pricing separately rather than ranking on it.
You pay the ongoing rate for eleven of your twelve months. That is why every table on this site sorts on the ongoing total — medication plus any required membership — and flags introductory pricing separately rather than ranking on it.
Split billing
The commonest way a price looks lower than it isRoughly half the offerings here use split billing — a medication price plus a separate membership — and it is the commonest way a price looks lower than it is. Eden quotes $99 for compounded semaglutide, but the membership is required for any medication, so the real price is $198. Hims and Hers quote $149 for the Wegovy pill; with the $149 membership it is $298. Ro quotes $199; it is $348.
A membership is not automatically bad. Mochi's $79 buys unlimited physician and dietitian access. PlushCare's $19.99 buys prior-authorisation support that can save you far more than it costs. The problem is not the fee — it is a comparison table that omits it. Every total in this database includes it.
A membership is not automatically bad. Mochi's $79 buys unlimited physician and dietitian access. PlushCare's $19.99 buys prior-authorisation support that can save you far more than it costs. The problem is not the fee — it is a comparison table that omits it. Every total in this database includes it.
Delivery formats — and the distinction that actually matters
Approved vs compounded, not oral vs injectableThis database covers three delivery formats, and they are not interchangeable. Injectable is the only format with trial evidence — every SURMOUNT and STEP result is a subcutaneous injection. Oral splits into two very different things: FDA-approved oral products (Foundayo, the Wegovy tablet), which have their own trial programmes, and compounded oral or ODT products, which have none. Sublingual — Shed's lozenges and drops, Henry Meds' sublingual tablets — likewise has no published trial evidence in this class.
The distinction that matters is not injectable-versus-oral. It is approved-versus-compounded. An FDA-approved oral pill has been tested in humans. A compounded sublingual drop has not, and its bioavailability is unpublished.
The distinction that matters is not injectable-versus-oral. It is approved-versus-compounded. An FDA-approved oral pill has been tested in humans. A compounded sublingual drop has not, and its bioavailability is unpublished.
What a commitment actually costs you
Before you commit to a long planA committed plan lowers the monthly figure and raises the risk. Before you sign one, ask what happens if you stop early — because a meaningful number of people do. Roughly one in five patients discontinues a GLP-1 within the first few months, most often because of gastrointestinal side effects. Others stop because insurance unexpectedly approves a brand product, or because they reach a goal weight, or because their circumstances change.
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Dose escalation: the risk the headline price hides
The question that matters more than the headline priceAsk what you will pay at your target maintenance dose, not at the starting dose. This is the difference between a programme that quotes a flat rate at every dose and one that escalates: MEDVi's compounded tirzepatide reaches $499/month at 10-15mg against a $399 headline; Shed's injectables rise with dose; Oak escalates $50-$75 per step. Over a year, on a full titration, the gap between a flat-rate programme and an escalating one can exceed $3,000 — far more than any difference in the advertised starting price.
| Provider | Price at higher doses | Risk |
|---|---|---|
| NexLife | Same at every covered dose | None — flat rate |
| Mochi Health | Same at all doses | None |
| Enhance.MD | Same at all doses | None |
| Eden | Same at all doses (compounded) | None on compounded |
| TrimRx | Flat ongoing rate | None |
| Oak Longevity | Flat across dosages | None |
| Shed | Increases at higher doses | Material — model at maintenance |
| MEDVi | $399 → $499 at 10-15mg | Material — $1,200/yr swing |
| LillyDirect (brand) | $299 → $449; $699 if you miss the 45-day refill | Material — set a reminder |
The insurance pathway
Do this before anything elseCheck your insurance before you compare any cash price. If your plan covers Zepbound or Wegovy, the manufacturer savings card can bring your cost to roughly $25/month — which beats every cash option on this site by an order of magnitude, for an FDA-approved product.
Coverage is most common through employer-sponsored commercial plans. Zepbound is excluded from Medicare Part D for weight loss and from most state Medicaid programmes. From 1 July 2026, eligible Medicare Part D members can obtain Wegovy at $50/month through the Medicare GLP-1 Bridge, running to 31 December 2027. Expect prior-authorisation paperwork: typically a BMI of 30+, or 27+ with a weight-related condition.
PlushCare ($19.99/month), Found and Mochi will handle that paperwork for you. If you have coverage, that is worth more than any cash discount.
Coverage is most common through employer-sponsored commercial plans. Zepbound is excluded from Medicare Part D for weight loss and from most state Medicaid programmes. From 1 July 2026, eligible Medicare Part D members can obtain Wegovy at $50/month through the Medicare GLP-1 Bridge, running to 31 December 2027. Expect prior-authorisation paperwork: typically a BMI of 30+, or 27+ with a weight-related condition.
PlushCare ($19.99/month), Found and Mochi will handle that paperwork for you. If you have coverage, that is worth more than any cash discount.
Dose caps: the other thing a low price can hide
A capped dose is not a discountWatch for dose caps as well as dose escalation. Noom Med's $199 compounded semaglutide programme is capped at 0.6mg — the STEP trials that established semaglutide's efficacy used 2.4mg. A capped programme is not a cheaper version of the same treatment; it is a lower-dose treatment, and the expected effect is correspondingly smaller. Noom's full-titration programme is $279.
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.
Frequently asked questions
How many providers and offerings are in this database?
18 providers and 86 priceable self-pay offerings, plus NexLife's six programmes at four plan lengths each. Every figure is a TOTAL monthly cost — medication plus any required membership. Competitor prices verified July 6, 2026; NexLife verified July 11, 2026.
What is the cheapest option in the whole database?
Excluding introductory rates, the cheapest FDA-approved option is Foundayo (oral) or the oral Wegovy tablet at $149/month. The cheapest compounded options are NexLife's semaglutide microdose at $110 and Oak Longevity's semaglutide at $133. But 'cheapest' has at least six distinct meanings and we keep them separate.
Why are some prices so much higher than others for the same drug?
Because some platforms resell brand-name drugs at close to retail. Eden lists brand Wegovy at $1,794/month total; NovoCare sells the identical drug for $149-$349. This is disclosed pricing, not fraud — but it is a four-to-twelve-fold difference for the same medicine.
Are the introductory rates real?
Yes, but they apply to one month. Noom's $79 becomes $199. MEDVi's $179 becomes $299. We flag all eleven intro rates and exclude them from every ranking.
Sources
- Provider pricing dataset, July 6, 2026 — 86 offerings across 18 providers. Third-party reported; labelled Reported pending our own capture.
- NexLife published self-pay program pages, transcribed July 11, 2026. Six programmes, four plan lengths.
- Eli Lilly — LillyDirect Zepbound and Foundayo self-pay pricing (marked Verified: manufacturer source).
- Novo Nordisk — NovoCare Pharmacy self-pay pricing (marked Verified: manufacturer source).
- U.S. Food and Drug Administration — compounding status and enforcement history.
- Our pricing-verification methodology.